← All companies

Pulse Biosciences, Inc.

Healthcare & Life Sci

Company overview

Pulse Biosciences develops and sells its nPulse technology, which uses Nanosecond Pulsed Field Ablation to treat soft tissue, mainly for cardiac rhythm disorders and benign thyroid nodules. The nPulse Vybrance Percutaneous Ablation System treats thyroid nodules, the nsPFA 360 Catheter Endocardial Ablation System is used for cardiac ablation, and CellFX nsPFA Technology is the underlying platform behind them. Pulse Biosciences, Inc is an H-1B sponsor.

Industry
Healthcare & Life Sci
Headquarters
United States

Filters

Create your account

Create an account to save jobs and track applications.